H Vernon Anderson
Affiliation: Baylor College of Medicine
- A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR)H Vernon Anderson
Texas Heart Institute and the University of Texas, Houston 77030, USA
J Am Coll Cardiol 39:1096-103. 2002..These data reconfirm overall acceptable results that are consistent with other reported data, but also confirm large variations between individual institutions...
- Clinical features and outcomes of carotid artery stenting by clinical expert consensus criteria: a report from the CARE registryH Vernon Anderson
Cardiology Division, University of Texas Health Science Center, Houston, Texas 77030, USA
Catheter Cardiovasc Interv 75:519-25. 2010..Our goal here was to investigate whether initial CAS procedures submitted to CARE conformed to CECD recommendations, and examine their clinical outcomes...
- Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendationsH Vernon Anderson
University of Texas Health Science Center, Houston, Texas, USA
Am J Cardiol 99:189-96. 2007..With further refinement, these methods should be able to be used as powerful analytic tools for quality assurance and appropriateness purposes...
- Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force GuidelinesH Vernon Anderson
University of Texas Health Science Center, Houston, TX 77030, USA
Circulation 112:2786-91. 2005..Our goal here was to investigate whether any relationship existed between the most recent ACC/AHA recommended indications for PCI and short term in-hospital outcomes...
- Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared to primary percutaneous coronary intervention alone results of the AMICO (Alliance for MyocardiaAli E Denktas
University of Texas Medical School and Memorial Hermann Heart and Vascular Institute, Houston, USA
JACC Cardiovasc Interv 1:504-10. 2008....
- Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction careAli E Denktas
University of Texas, Health Science Center at Houston and Memorial Hermann Heart and Vascular Institute, Houston, Texas, USA
JACC Cardiovasc Interv 4:599-604. 2011..This review will discuss the importance of total ischemic time in STEMI...
- Do postmarketing surveillance studies represent real-world populations? A comparison of patient characteristics and outcomes after carotid artery stentingRobert W Yeh
Cardiology Division, GRB 800, Massachusetts General Hospital, Boston, MA 02144, USA
Circulation 123:1384-90. 2011..Whether PMS studies are representative of carotid artery stenting in routine clinical practice has not been established...
- Sirolimus or paclitaxel drug-eluting stents for treatment of chronic total occlusions of coronary arteries: much ado about very littlePhil Hemstreet
Cardiology Division, University of Texas Health Science Center, Houston, Texas, USA
J Invasive Cardiol 18:209-10. 2006
- Prehospital 12-Lead Electrocardiogram within 60 Minutes Differentiates Proximal versus Nonproximal Left Anterior Descending Artery Myocardial InfarctionRobert A Aertker
University of Texas at Houston Medical School, Department of Internal Medicine Division of Cardiology, Houston, Texas
West J Emerg Med 12:408-13. 2011..We sought to determine if the 12 lead ECG is capable of predicting proximal LAD artery occlusions...
- Contrast-induced nephropathy: back to basicsFernando Boccalandro
University of Texas Health Science Center, Houston, TX, USA
J Invasive Cardiol 15:317-8. 2003
- Fibrinolysis and coronary stenting for treatment of an acute inferior myocardial infarction after ascending aortic aneurysm repair with conduit coronary graftsAli H Shakir
Division of Cardiology, University of Texas-Houston and Memorial Hermann Heart, Houston, Texas 77030, USA
J Invasive Cardiol 18:E305-6. 2006
- Abciximab administration and clinical outcomes after percutaneous intervention for in-stent restenosisAli Moustapha
University of Texas Medical School at Houston and Memorial Hermann Hospital, Houston, Texas, USA
Catheter Cardiovasc Interv 56:184-7. 2002..Randomized trials are needed to identify the role of platelet glycoprotein IIb/IIIa inhibitors in the management of in-stent restenosis...
- Development of a risk adjustment mortality model using the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) experience: 1998-2000Richard E Shaw
San Francisco Heart Institute at Seton Medical Center, Daly City, California 94015, USA
J Am Coll Cardiol 39:1104-12. 2002..We sought to develop and evaluate a risk adjustment model for in-hospital mortality following percutaneous coronary intervention (PCI) procedures using data from a large, multi-center registry...
- Prognosis in the thrombolysis in myocardial ischemia III registry according to the Braunwald unstable angina pectoris classificationBenjamin M Scirica
Cardiovascular Division, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
Am J Cardiol 90:821-6. 2002..Given their high risk for adverse events, patients with secondary UAP should be treated aggressively...
- Updated risk adjustment mortality model using the complete 1.1 dataset from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR)Richard E Shaw
Joint Cardiac Program Sutter Health System, San Francisco, California 94115, USA
J Invasive Cardiol 15:578-80. 2003..1 version of the American College of Cardiology National Cardiovascular Data Registry (ACC-NCR)...
- Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current "stent era" of coronary interventions (from the ACC-National CardiRonald J Krone
Department of Medicine, Washington University, St Louis, Missouri, USA
Am J Cardiol 92:389-94. 2003....
- The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but associated with higher vascular complications and cardiac mortalityAbid R Assali
Cardiac Catheterization Laboratory, Rabin Medical Center, Petach Tikva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Catheter Cardiovasc Interv 59:195-9. 2003..9; 95% CI = 1.3-11.5; P = 0.015). Although PCI is technically successful in patients aged > or = 75 years; it is associated with more acute cardiac and vascular complications and higher in-hospital cardiac mortality...
- Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefitH Vernon Anderson
J Am Coll Cardiol 42:2060-2. 2003
- The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromesRichard G Bach
Cardiovascular Division, Washington University Medical Center, St Louis, Missouri 63110, USA
Ann Intern Med 141:186-95. 2004..Although increasing age is an important risk factor for adverse outcome among patients with acute coronary syndromes, elderly patients are more often managed conservatively...
- Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction modelLloyd W Klein
Rush Medical College, Chicago, Illinois, USA
Am J Cardiol 96:35-41. 2005..In conclusion, analysis of patients from the ACC-NCDR who underwent emergency PCI for acute myocardial infarction in the presence of cardiogenic shock shows an in-hospital mortality rate of approximately 60% when PCI is attempted...
- Contemporary view of the acute coronary syndromesAli Moustapha
Louisiana State University, Shreveport, USA
J Invasive Cardiol 15:71-9. 2003
- Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR)Tracy Y Wang
J Am Coll Cardiol 51:2068-74. 2008
- Drug-eluting stents: life insurance with a better death benefitH Vernon Anderson
J Am Coll Cardiol 51:2025-7. 2008
- The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implicationsChristopher J White
Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
Catheter Cardiovasc Interv 71:721-5. 2008..Finally, the CARE Registry satisfies the Center for Medicare and Medicaid Services (CMS) data reporting criteria for reimbursement...
- Pre-hospital reduced-dose fibrinolysis coupled with urgent percutaneous coronary intervention reduces time to reperfusion and improves angiographic perfusion score compared with prehospital fibrinolysis alone or primary percutaneous coronary intervention:Richard W Smalling
J Am Coll Cardiol 50:1612-4. 2007
- Drug-eluting stents for acute myocardial infarctionH Vernon Anderson
J Am Coll Cardiol 49:1931-3. 2007
- Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry)Sameer K Mehta
Department of Cardiology, The Mid America Heart Institute, Kansas City, Missouri, USA
Am J Cardiol 100:1114-8. 2007..EPD use was independently associated with a lower incidence of no-reflow (OR 0.68, p = 0.032), but not in-hospital mortality (1.0% vs 0.9%, p = NS). In conclusion, in current practice, EPDs are used in <25% of SVG PCI procedures...